CHRNA4 and Alzheimer disease: Our group used 2-[18F]fluoro-3-(2(S)azetidinylmethoxy)pyridine (2FA) and positron emission tomography [35–37] to measure α4β2 nicotinic cholinergic receptors (nAChR) in vivo in AD [38].